Baird Maintains Outperform on Boston Scientific, Raises Price Target to $84
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Rescott maintains an Outperform rating on Boston Scientific (NYSE:BSX) and raises the price target from $79 to $84.
April 25, 2024 | 10:43 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst David Rescott maintains an Outperform rating on Boston Scientific and raises the price target from $79 to $84.
The increase in price target by Baird reflects a positive outlook on Boston Scientific's future performance, likely leading to increased investor confidence and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100